Alongside the complete kit, TheWell Bioscience has released the RocketCell (TM) iPSC Xeno-Free Growth Medium. Available as a standalone product, this xeno-free medium is designed for researchers who ...
Cellistic has unveiled three new GMP manufacturing platforms designed to advance iPSC-derived cell therapies across ...
As of Thursday, January 08, Century Therapeutics, Inc.’s IPSC share price has surged by 30.65%, which has investors ...
Zacks Investment Research on MSN
Fast-paced momentum stock Century Therapeutics (IPSC) is still trading at a bargain
Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that ...
Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.
Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.
XCells Biotechnologies, a provider of human cell-based solutions and custom iPSC services, has appointed Steve Smith as CEO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback